Alexei Savchenko

Associate Professor

University of Calgary
Country flagCanada

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (7)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

The survival of Legionella spp. as intracellular pathogens relies on the combined action of protein effectors delivered inside their eukaryotic hosts by the Dot/Icm ( d efective in o rganelle t rafficking/ i ntra c ellular m ultiplication) type IVb secretion system. The specific repertoire of effector arsenals varies dramatically across over 60 known species of this genera with Legionella pneumophila responsible for most cases of Legionnaires’ disease in humans encoding over 360 Dot/Icm effectors. However, a small subset of “core” effectors appears to be conserved across all Legionella species raising an intriguing question of their role in these bacteria’s pathogenic strategy, which for most of these effectors remains unknown. L. pneumophila Lpg0103 effector, also known as VipF, represents one of the core effector families that features a tandem of Gcn5-related N-acetyltransferase (GNAT) domains. Here, we present the crystal structure of the Lha0223, the VipF representative from Legionella hackeliae in complex with acetyl-coenzyme A determined to 1.75 Å resolution. Our structural analysis suggested that this effector family shares a common fold with the two GNAT domains forming a deep groove occupied by residues conserved across VipF homologs. Further analysis suggested that only the C-terminal GNAT domain of VipF effectors retains the active site composition compatible with catalysis, whereas the N-terminal GNAT domain binds the ligand in a non-catalytical mode. We confirmed this by in vitro enzymatic assays which revealed VipF activity not only against generic small molecule substrates, such as chloramphenicol, but also against poly-L-lysine and histone-derived peptides. We identified the human eukaryotic translation initiation factor 3 (eIF3) complex co-precipitating with Lpg0103 and demonstrated the direct interaction between the several representatives of the VipF family, including Lpg0103 and Lha0223 with the K subunit of eIF3. According to our data, these interactions involve primarily the C-terminal tail of eIF3-K containing two lysine residues that are acetylated by VipF. VipF catalytic activity results in the suppression of eukaryotic protein translation in vitro , revealing the potential function of VipF “core” effectors in Legionella ’s pathogenic strategy. IMPORTANCE By translocating effectors inside the eukaryotic host cell, bacteria can modulate host cellular processes in their favor. Legionella species, which includes the pneumonia-causing Legionella pneumophila, encode a widely diverse set of effectors with only a small subset that is conserved across this genus. Here, we demonstrate that one of these conserved effector families, represented by L. pneumophila VipF (Lpg0103), is a tandem Gcn5-related N-acetyltr

Year:

2024

Collaborators (7)

Dominika Borek

University of Texas Southwestern Medical Center

UNITED STATES
View details

Alexander Yakunin

Professor

University of Toronto

CANADA
View details

Leah E. Cowen

University of Toronto

CANADA
View details

Danica Galonić Fujimori

University of California, San Francisco

UNITED STATES
View details

David R. Andes

Professor

University of Wisconsin School of Medicine and Public Health

UNITED STATES
View details

Elina Karimullina

University of Calgary

CANADA
View details

Peter Stogios

Senior Research Associate

University of Toronto

CANADA
View details